Prestige News

Total 70
Number Thumbnail Title Author Date Votes Views
40 Prestige Biopharma IDC Signs Joint Development Agreement with Geovista for Companion Animal Therapeutics
김** | 2025.09.16 | Votes 0 | Views 1041
김** 2025.09.16 0 1041
39 Prestige Biopharma IDC Selected as a Core Research center in Korea’s ARPA-H Project
김** | 2025.08.20 | Votes 0 | Views 994
김** 2025.08.20 0 994
38 PPrestige Biopharma Secures European Patent for Pancreatic Cancer Antibody PBP1510
김** | 2025.08.01 | Votes 0 | Views 1455
김** 2025.08.01 0 1455
37 Prestige Biopharma IDC Files Patent for Anti-CTHRC1 Antibody Combination Therapy for Solid Tumors
we******** | 2025.07.28 | Votes 0 | Views 904
we******** 2025.07.28 0 904
36 Prestige Biopharma IDC Hosts Regional R&D Engagement Tour with BISTEP and Civic Groups
we******** | 2025.07.16 | Votes 0 | Views 881
we******** 2025.07.16 0 881
35 Prestige Biopharma IDC Shares Antibody-Based Drug Research with KAIST Professors
김** | 2025.07.10 | Votes 0 | Views 989
김** 2025.07.10 0 989
34 Prestige Biopharma Highlights PBP1510 Clinical Progress at ASCO 2025
we******** | 2025.06.04 | Votes 0 | Views 2013
we******** 2025.06.04 0 2013
33 Prestige Biopharma Signs 31 European Licensing and Supply Agreement with Teva for Tuznue®
we******** | 2025.05.26 | Votes 0 | Views 1343
we******** 2025.05.26 0 1343
32 Prestige Biopharma Publishes Preclinical Study of Biosimilar Tuznue® in SCI Journal Drug in R&D
we******** | 2025.04.16 | Votes 0 | Views 995
we******** 2025.04.16 0 995
31 Busan-Jinhae Free Economic Zone Commissioner Visits Prestige Biopharma IDC to Discuss Biopharma Industry Collaboration
we******** | 2025.04.03 | Votes 0 | Views 867
we******** 2025.04.03 0 867